Figure 1.

The 5 year overall survival curves indicated a statistical significance (p = 0.02) of the overall survival difference between patients with difference phenotypes. The 5 year overall survival distribution was 91.0% in Fya + Fyb+, 86.5% in Fya + Fyb-, 83.3% in Fya-Fyb + and 75.0% in Fya-Fyb-.

Liu et al. BMC Cancer 2012 12:374   doi:10.1186/1471-2407-12-374
Download authors' original image